OCUL
Ocular Therapeutix Inc.
Company Overview
| Mkt Cap | $2.11B | Price | $11.66 |
| Volume | 2.64M | Change | -1.35% |
| P/E Ratio | -10.9 | Open | $11.81 |
| Revenue | $63.7M | Prev Close | $11.82 |
| Net Income | $-193.5M | 52W Range | $5.79 - $13.85 |
| Div Yield | N/A | Target | $21.00 |
| Overall | 70 | Value | 50 |
| Quality | -- | Technical | 90 |
No chart data available
Stock Overview
Updated DailyOcular Therapeutix Inc. (OCUL) is a leading Healthcare company in the Biotechnology industry, currently trading at $11.66 with a market capitalization of $2.11 billion. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows OCUL with a volume of 2.64 million shares. The stock opened down 0.08% from yesterday's close of $11.82. Current analyst estimates project earnings of $-1.48 per share for this year, with next year targeting $-1.39.
OCUL demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including XENT, ANIK, HAE, SRDX.
Key investment considerations for OCUL include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 80.1%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 2, 2025 at 06:48 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OCUL | $11.66 | -1.4% | 2.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |